Expression of concern
Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor
Paper Information
Record ID:
21307
Publication Date:
December 28, 2010
Retraction Date:
September 24, 2019
(6.2 years years ago)
Subjects:
Institutions:
- Division of Radiation Biology, Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, Greehey Children's Cancer Research Institute, San Antonio, Texas, United States of America
- Department of Biostatistics, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas, United States of America
- Department of Pathology and Laboratory Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, Kansas, United States of America
- Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, Kansas, United States of America
Country:
🇺🇸 United StatesArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reason:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1371/journal.pone.0223138Citations (113)
113
Total Citations22
Post-Retraction(19.5%)
77
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
16
After 2+ years
1977
Days since retraction (latest)
Paper citing Resveratrol Enhances Antitumor Activity of TRAIL i...
Unknown Authors
Unknown Journal
Published: Dec 2011
2854 days before retraction
Paper citing Resveratrol Enhances Antitumor Activity of TRAIL i...
Unknown Authors
Unknown Journal
Published: Nov 2011
2874 days before retraction
Paper citing Resveratrol Enhances Antitumor Activity of TRAIL i...
Unknown Authors
Unknown Journal
Published: Nov 2011
2884 days before retraction
Verticillin A Overcomes Apoptosis Resistance in Human Colon Carcinoma through DNA Methylation-Dependent Upregulation of BNIP3
Feiyan Liu, Qianqian Liu, Dafeng Yang et al. (7 authors)
Cancer Research
Open Access
Published: Sep 2011
58 citations
58 citations
2933 days before retraction
Paper citing Resveratrol Enhances Antitumor Activity of TRAIL i...
Unknown Authors
Unknown Journal
Published: Aug 2011
2946 days before retraction
Paper citing Resveratrol Enhances Antitumor Activity of TRAIL i...
Unknown Authors
Unknown Journal
Published: Aug 2011
2976 days before retraction
Paper citing Resveratrol Enhances Antitumor Activity of TRAIL i...
Unknown Authors
Unknown Journal
Published: Jul 2011
2979 days before retraction
Paper citing Resveratrol Enhances Antitumor Activity of TRAIL i...
Unknown Authors
Unknown Journal
Published: Jul 2011
2990 days before retraction
Isotretinoin and FoxO1
Bodo C. Melnik
Dermato-Endocrinology
Open Access
Published: Jul 2011
59 citations
59 citations
3007 days before retraction
Paper citing Resveratrol Enhances Antitumor Activity of TRAIL i...
Unknown Authors
Unknown Journal
Published: Jun 2011
3017 days before retraction
TRAIL-mediated signaling in prostate, bladder and renal cancer
Christina Voelkel‐Johnson
Nature Reviews Urology
Published: Jun 2011
42 citations
42 citations
3024 days before retraction
Paper citing Resveratrol Enhances Antitumor Activity of TRAIL i...
Unknown Authors
Unknown Journal
Published: May 2011
3068 days before retraction
Paper citing Resveratrol Enhances Antitumor Activity of TRAIL i...
Unknown Authors
Unknown Journal
Published: Apr 2011
3079 days before retraction
Quick Stats
Total Citations:
113
Years Since Retraction:
6.2 years
Open Access:
Yes
Last Checked:
Never